Stroke Prevention Guideline Update
![](https://www.ceimpact.com/wp-content/uploads/course-images-solidbg/2022/04/pharmacist/4322-768x768.jpg)
Stroke Prevention Guideline Update
The American Heart Association’s Secondary Stroke Prevention Guideline calls for multidisciplinary team management of patients. Take this course to learn about the guidelines and how pharmacists should apply the “top 10 take-home messages” called out for successful patient outcomes.
Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. List signs, symptoms, and diagnostic criteria for acute ischemic stroke based on the 2021 AHA Stroke Guidelines
2. Assess vascular risk factors in diverse patient populations
3. Identify appropriate indications for antithrombotic use in stroke prevention for persons with atrial fibrillation
4. Apply treatment recommendations for secondary stroke prevention using the updated 2021 AHA Stroke Guidelines
5. Formulate evidence based recommendations for treating persons after an acute ischemic stroke
Olivia J. Morgan, PharmD, BCCCP, BCGP
Clinical Pharmacist Specialist
Grady Health System
Olivia J. Morgan has no relevant financial relationships to disclose.
Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: April 1, 2022
Planned Expiration Date: April 1, 2025
Copyright 2022, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.
RV2-1.24
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
Duration | 1h 0m |
---|---|
Topic Designator | Disease State/Drug Therapy |
ACPE | Yes |
ACPE Topic | 01 Drug Therapy |
Role | Pharmacist |
Media-Type | On-Demand |
Release Date | 4/1/22 |
CEUs | 0.1 |
Rating | 4 |
ACPE Number | 0107-0000-22-111-H01-P |
This course is in our subscription.
Related products
-
A Non-irritable Review of Irritable Bowel Syndrome (IBS) Guidelines
In Courses, PharmacistRated 0 out of 5$24.00 -